Cryogenic spray, cutaneous - ARTG 368091
Access comprehensive regulatory information for Cryogenic spray, cutaneous in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is registered under ARTG number 368091 and sponsored by Emergo Asia Pacific Pty Ltd T/a Emergo Australia, manufactured by CryoConcepts LP in United States of America. The device registration started on June 03, 2021.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
This multi-use disposable device is intended for the surgical destruction of target tissue by applying cryogenic gases at extreme low temperature. This list below shows examples of the types of lesions that can be treated. • Genital Lesions • Seborrheic Keratosis • Verruca Plantaris • Verruca Plana • Lentigo • Molluscum Contagiosum • Skin Tags • Verruca Vulgaris • Actinic Keratosis